The rarity, severity and complexity of paediatric rheumatic diseases make progress in treating these diseases a challenge. In 2017, a new series of recommendations for treatment, studies that unravel the complexity of juvenile idiopathic arthritis and clinical trials that tackle sight-threatening uveitis have helped to improve paediatric care.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kuemmerle-Deschner, J. B. et al. Recommendations for collaborative paediatric research including biobanking in Europe: a single hub and access point for paediatric rheumatology in Europe (SHARE) initiative. Ann. Rheum. Dis. 10.1136/annrheumdis-2017-211904 (2017).
Ombrello, M. J. et al. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. Ann. Rheum. Dis. 76, 906–913 (2017).
Ramanan, A. V. et al. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N. Engl. J. Med. 376, 1637–1646 (2017).
Enders, F. B. et al. Consensus-based recommendations for the management of juvenile dermatomyositis. Ann. Rheum. Dis. 76, 329–340 (2017).
Groot, N. et al. European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative. Ann. Rheum. Dis. 76, 1637–1641 (2017).
Groot, N. et al. European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative. Ann. Rheum. Dis. 76, 1788–1796 (2017).
Groot, N. et al. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann. Rheum. Dis. 76, 1965–1973 (2017).
Hinks, A. et al. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat. Genet. 45, 664–669 (2013).
European Medicines Agency. EU regulatory workshop — ophthalmology — summary and report. Clinical development, scientific advice and paediatric investigation plans. EMA http://www.ema.europa.eu/docs/en_GB/document_library/Report/2012/09/WC500131815.pdf (2012).
Woodcock, J. & LaVange, L. M. Master protocols to study multiple therapies, multiple diseases, or both. N. Engl. J. Med. 377, 62–70 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Beresford, M., Ramanan, A. Child-centred research is the key to progress. Nat Rev Rheumatol 14, 69–70 (2018). https://doi.org/10.1038/nrrheum.2017.214
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2017.214